InVivo Therapeutics (NASDAQ:NVIV) Research Coverage Started at StockNews.com
StockNews.com started coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Free Report) in a research report sent to investors on Saturday morning. The brokerage issued a sell rating on the biotechnology company’s stock. InVivo Therapeutics Stock Up 25.3 % NVIV opened at $0.89 on Friday. The company has a fifty day moving average of $0.90 […]
6 Dec 01:56 · The Cerbat Gem